EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

A low‐energy total diet replacement program demonstrates a favorable safety profile and improves liver disease severity in nonalcoholic steatohepatitis

Dimitrios A Koutoukidis iD, Ferenc E Mozes iD, Susan A Jebb iD, Jeremy W Tomlinson iD, Michael Pavlides iD, Francesca Saffioti iD, Rosemary Huntriss, Paul Aveyard iD, Jeremy F Cobbold

Obesity · 2023

DOI: 10.1002/oby.23793 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Obesity, 2023. Verfasst von Dimitrios A Koutoukidis und 8 weiteren Autor:innen. Beteiligte Einrichtung: Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Medical Research Council, Department of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Low‐energy diets are used to treat obesity and diabetes, but there are fears that they may worsen liver disease in patients with nonalcoholic steatohepatitis (NASH) and significant‐to‐advanced fibrosis.

Methods

In this 24‐week single‐arm trial, 16 adults with NASH, fibrosis, and obesity received one‐to‐one remote dietetic support to follow a low‐energy (880 kcal/d) total diet replacement program for 12 weeks and stepped food reintroduction for another 12 weeks. Liver disease severity was blindly evaluated (magnetic resonance imaging proton density fat fraction [MRI‐PDFF], iron‐corrected T1 [cT1], liver stiffness on magnetic resonance elastography [MRE], and liver stiffness on vibration‐controlled transient elastography [VCTE]). Safety signals included liver biochemical markers and adverse events.

Results

A total of 14 participants (87.5%) completed the intervention. Weight loss was 15% (95% CI: 11.2%–18.6%) at 24 weeks. Compared with baseline, MRI‐PDFF reduced by 13.1% (95% CI: 8.9%–16.7%), cT1 by 159 milliseconds (95% CI: 108–216.5), MRE liver stiffness by 0.4 kPa (95% CI: 0.1–0.8), and VCTE liver stiffness by 3.9 kPa (95% CI: 2.6–7.2) at 24 weeks. The proportions with clinically relevant reductions in MRI‐PDFF (≥30%), cT1 (≥88 milliseconds), MRE liver stiffness (≥19%), and VCTE liver stiffness (≥19%) were 93%, 77%, 57%, and 93%, respectively. Liver biochemical markers improved. There were no serious intervention‐related adverse events.

Conclusions

The intervention demonstrates high adherence, favorable safety profile, and promising efficacy as a treatment for NASH. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseAdultHumansLiverMagnetic Resonance ImagingPatient AcuityBiomarkersObesityFibrosisLiver Cirrhosis

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
  • National Institute for Health and Care Research Oxford Biomedical Research Centre, Oxford, UK.
  • Oxford Centre for Clinical Magnetic Resonance Research, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
  • Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
  • Department of Gastroenterology and Hepatology, John Radcliffe Hospital, Oxford University Hospitals National Health Service Foundation Trust, Oxford, UK.
  • Oviva, London, UK.

ORCID-Profile: Dimitrios A Koutoukidis, Ferenc E Mozes, Susan A Jebb, Jeremy W Tomlinson, Michael Pavlides, Francesca Saffioti, Paul Aveyard

Förderung

  • Medical Research Council
  • Department of Health

Zitieren

APA

Koutoukidis, D. A., Mozes, F. E., Jebb, S. A., Tomlinson, J. W., Pavlides, M., Saffioti, F., Huntriss, R., Aveyard, P., & Cobbold, J. F. (2023). A low‐energy total diet replacement program demonstrates a favorable safety profile and improves liver disease severity in nonalcoholic steatohepatitis. Obesity. https://doi.org/10.1002/oby.23793

Vancouver

Koutoukidis DA, Mozes FE, Jebb SA, Tomlinson JW, Pavlides M, Saffioti F, et al. A low‐energy total diet replacement program demonstrates a favorable safety profile and improves liver disease severity in nonalcoholic steatohepatitis. Obesity. 2023. doi:10.1002/oby.23793

BibTeX
@article{Koutoukidis2023,
  author = {Koutoukidis, Dimitrios A and Mozes, Ferenc E and Jebb, Susan A and Tomlinson, Jeremy W and Pavlides, Michael and Saffioti, Francesca and Huntriss, Rosemary and Aveyard, Paul and Cobbold, Jeremy F},
  title = {A low‐energy total diet replacement program demonstrates a favorable safety profile and improves liver disease severity in nonalcoholic steatohepatitis},
  journal = {Obesity},
  year = {2023},
  doi = {10.1002/oby.23793}
}
Kostenlos starten →